MAPK8 and neoplasm: The ability of these compounds, particularly those based on copper, nickel, cobalt, and noble metals, to simultaneously target multiple cellular pathways, such as reactive oxygen species (ROS) generation and activation of the JNK/p38 pathways, reinforces their potential as therapeutic agents directed at CSCs, which are responsible for tumor resistance and relapse.